Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Vocci

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Cardiovascular Electrophysiology|July 14, 2006
Intravenous cocaine and QT variabilityMark C P Haigney, Shama Alam, Scot Tebo, et al.
Substance Abuse and Rehabilitation|July 2, 2021
Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality MeasuresDiana E Clarke, Adila Ibrahim, Benjamin Doty, et al.
Journal of Addiction Medicine|June 3, 2026
Advancing Kratom Science and Regulation: A Comparative Framework With CannabisYnhi T Thomas, Mubeen Iqbal, Chung J Mun, et al.
Drug and Alcohol Dependence|May 30, 2006
Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependenceAhmed Elkashef, Paul J Fudala, Liza Gorgon, et al.
Addiction (Abingdon, England)|August 8, 2013
Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxoneRichard N Rosenthal, Walter Ling, Paul Casadonte, et al.
Addiction (Abingdon, England)|February 26, 2005
Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependenceAhmed Elkashef, Tyson H Holmes, Daniel A Bloch, et al.
CNS Neuroscience & Therapeutics|June 21, 2018
A cholecystokinin B receptor antagonist and cocaine interaction, phase I studyAhmed Elkashef, James Robert Brašić, Louis R Cantelina, et al.
Synapse (New York, N.Y.)|July 6, 2004
6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matterYu-Shin Ding, Joanna S Fowler, Jean Logan, et al.
Addiction (Abingdon, England)|May 12, 2007
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacityAhmed Elkashef, Richard A Rawson, Edwina Smith, et al.
Addiction (Abingdon, England)|February 26, 2005
Cocaine Rapid Efficacy Screening Trials (CREST): lessons learnedKyle M Kampman, Deborah Leiderman, Tyson Holmes, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Cardiovascular Electrophysiology|July 14, 2006
Intravenous cocaine and QT variabilityMark C P Haigney, Shama Alam, Scot Tebo, et al.
Substance Abuse and Rehabilitation|July 2, 2021
Addiction Medicine Practice-Based Research Network (AMNet): Assessment Tools and Quality MeasuresDiana E Clarke, Adila Ibrahim, Benjamin Doty, et al.
Journal of Addiction Medicine|June 3, 2026
Advancing Kratom Science and Regulation: A Comparative Framework With CannabisYnhi T Thomas, Mubeen Iqbal, Chung J Mun, et al.
Drug and Alcohol Dependence|May 30, 2006
Double-blind, placebo-controlled trial of selegiline transdermal system (STS) for the treatment of cocaine dependenceAhmed Elkashef, Paul J Fudala, Liza Gorgon, et al.
Addiction (Abingdon, England)|August 8, 2013
Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxoneRichard N Rosenthal, Walter Ling, Paul Casadonte, et al.
Addiction (Abingdon, England)|February 26, 2005
Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependenceAhmed Elkashef, Tyson H Holmes, Daniel A Bloch, et al.
CNS Neuroscience & Therapeutics|June 21, 2018
A cholecystokinin B receptor antagonist and cocaine interaction, phase I studyAhmed Elkashef, James Robert Brašić, Louis R Cantelina, et al.
Synapse (New York, N.Y.)|July 6, 2004
6-[18F]Fluoro-A-85380, a new PET tracer for the nicotinic acetylcholine receptor: studies in the human brain and in vivo demonstration of specific binding in white matterYu-Shin Ding, Joanna S Fowler, Jean Logan, et al.
Addiction (Abingdon, England)|May 12, 2007
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacityAhmed Elkashef, Richard A Rawson, Edwina Smith, et al.
Addiction (Abingdon, England)|February 26, 2005
Cocaine Rapid Efficacy Screening Trials (CREST): lessons learnedKyle M Kampman, Deborah Leiderman, Tyson Holmes, et al.
Pageof 4